Pitfalls of Cost-Effectiveness Analysis in Practice: A TRD Case Example in the United States with Esketamine Versus Oral Antidepressants.
Level V
Where this comes from
- Record sourced from PubMed, PMID 32223604.
- Also identified by DOI 10.18553/jmcp.2020.26.4.568 and PMC identifier 10391107.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The writing of this letter was supported by Janssen Scientific Affairs. The authors are employees of Janssen Scientific Affairs or Janssen Global Services (Johnson & Johnson).
Medical subject headings
- Ketamine